It has been shown that the IL-33/ST2 signaling pathway is activated in diabetic nephropathy (Elsherbiny et al., 2020), and endothelial dysfunction can be induced during the development of diabetic nephropathy (Xue et al., 2020). The gene discussed is IL33; the disease is endothelial dysfunction.